Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
← Back to rankings
ACRV
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -53.7%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
acrivon
therapeutics
nasdaq
trading
clinical
patients
compared
precision
data
announced
last
proteomics
tuesday
cancer
study
platform
based
2023
rating
phase
ACRV
Acrivon Therapeutics, Inc. Common Stock
StonvexStonvexStonvexStonvex